These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 12059865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy.
    Stewart WC, Stewart JA, Jackson AL.
    Acta Ophthalmol Scand; 2002 Jun; 80(3):277-81. PubMed ID: 12059866
    [Abstract] [Full Text] [Related]

  • 3. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik B, Shams N, Unoprostone Monotherapy Study Group-EU.
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
    Sharpe ED, Henry CJ, Mundorf TK, Day DG, Stewart JA, Jenkins JN, Stewart WC.
    Eye (Lond); 2005 Jan; 19(1):35-40. PubMed ID: 15094733
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y, Tanino T, Kimura I, Mashima Y, Oguchi Y.
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone).
    Yamamoto T, Kitazawa Y, Azuma I, Masuda K.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S99-103. PubMed ID: 9154284
    [Abstract] [Full Text] [Related]

  • 13. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone.
    Shimazaki J, Hanada K, Yagi Y, Yamagami J, Ishioka M, Shimmura S, Tsubota K.
    Br J Ophthalmol; 2000 Nov; 84(11):1250-4. PubMed ID: 11049949
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of topical beta-blockers during exercise.
    Atkins JM, Pugh BR, Timewell RM.
    Am J Ophthalmol; 1985 Feb 15; 99(2):173-5. PubMed ID: 3970121
    [Abstract] [Full Text] [Related]

  • 15. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.
    Am J Ophthalmol; 2001 May 15; 131(5):636-42. PubMed ID: 11336940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An evaluation of the effect of unoprostone isopropyl 0.15% on ocular hemodynamics in normal-tension glaucoma patients.
    Beano F, Orgül S, Stümpfig D, Gugleta K, Flammer J.
    Graefes Arch Clin Exp Ophthalmol; 2001 Feb 15; 239(2):81-6. PubMed ID: 11372549
    [Abstract] [Full Text] [Related]

  • 19. Systemic beta-blockade with once daily Betimol or Timoptic-XE.
    Stewart WC, Cate EA, Stewart JA.
    J Ocul Pharmacol Ther; 1999 Jun 15; 15(3):225-31. PubMed ID: 10385131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.